We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VNT:NYSEVontier Corporation Analysis

Data as of 2026-07-30 - not real-time

$32.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Vontier trades at $32.25, roughly double the DCF-derived fair value of $16.23, suggesting the market is pricing in strong growth expectations despite the current valuation gap. The stock’s trailing P/E of 11.6 is well below the industry average of 31.2, and a forward P/E of 8.7 reinforces its relative cheapness on a earnings basis, while a robust ROE of 35% highlights efficient capital use. Technical signals are mixed: the 20‑day SMA (29.96) sits below the price, the MACD is bullish, yet the RSI of 66 points to near‑overbought conditions and volume is trending down, indicating short‑term caution. Fundamentally, the company delivers solid margins (gross 47%, operating 18%) and generates free cash flow of $291 M, but a debt‑to‑equity ratio of 153% raises leverage concerns.
The recent inclusion on Newsweek’s World’s Greenest Companies list underscores a credible ESG narrative that could attract sustainability‑focused capital, while the low dividend payout (0.3% yield, 3.5% payout) suggests ample room to maintain or modestly increase distributions. Overall, Vontier appears undervalued from a relative earnings perspective but appears over‑priced relative to intrinsic DCF estimates, presenting a nuanced risk‑reward profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI approaching overbought
  • Decreasing volume trend
  • Price near resistance at $33.21

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Low trailing P/E vs industry peers
  • Strong ROE and cash flow generation
  • High leverage that may require monitoring

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic positioning in EV charging and mobility tech
  • ESG recognition boosting demand from green investors
  • Upside potential of ~23% to analyst median target of $38.5

Key Metrics & Analysis

Financial Health

Revenue Growth1.30%
Profit Margin13.37%
P/E Ratio11.6
ROE34.78%
ROA8.46%
Debt/Equity153.15
P/B Ratio3.6
Op. Cash Flow$447.1M
Free Cash Flow$291.4M
Industry P/E31.2

Technical Analysis

TrendNeutral
RSI66.3
Support$28.15
Resistance$33.21
MA 20$29.96
MA 50$29.40
MA 200$35.46
MACDBullish
VolumeDecreasing
Fear & Greed Index84.54

Valuation

Fair Value$16.23
Target Price$39.70
Upside/Downside23.10%
GradeOvervalued
TypeBlend
Dividend Yield0.30%

Risk Assessment

Beta1.07
Volatility28.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.